Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.58 |
| ▸ | MEN1 | O00255 | 4/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.58 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.53 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 4/20 | 0.51 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | CDK4 | P11802 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | CCND1 | P24385 | 1/20 | 0.50 |
| ▸ | MGLL | Q99685 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.45 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.45 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.45 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL159025 | 1.00 | ALDH1A1 (0.58) | ALDH1A1MEN1KMT2ANOTUMSMN1; SMN2 | |
| SCHEMBL174780 | 0.94 | ALDH1A1 (0.51) | ALDH1A1MEN1KMT2ANOTUMSMN1; SMN2 | |
| SCHEMBL23601610 | 0.92 | MEN1 (0.50) | ALDH1A1MEN1KMT2ANOTUMSMN1; SMN2 | |
| SCHEMBL12013900 | 0.92 | MEN1 (0.50) | ALDH1A1MEN1KMT2ANOTUMSMN1; SMN2 | |
| SCHEMBL142091 | 0.86 | ALDH1A1 (0.59) | ALDH1A1MEN1KMT2ANOTUMSMN1; SMN2 | |
| SCHEMBL28443197 | 0.86 | MEN1 (0.46) | ALDH1A1MEN1KMT2ANOTUMSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL22582303 | 0.84 | ALDH1A1 (0.57) | ALDH1A1MEN1KMT2ANOTUMSMN1; SMN2 | |
| Bromide SCHEMBL29602074 | 0.84 | ALDH1A1 (0.57) | ALDH1A1MEN1KMT2ANOTUMSMN1; SMN2 | |
| SCHEMBL23188902 | 0.81 | NOTUM (0.46) | ALDH1A1MEN1KMT2ANOTUMSMN1; SMN2 | |
| SCHEMBL16707769 | 0.79 | TP53 (0.42) | ALDH1A1MEN1KMT2AMAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118125962-A | Method for preparing 2-aminomethylindoline-3-carboxylic acid from carbon dioxide | 常州大学 | 2024-06-04 | — | — | CN | claimed |
| CN-117160451-A | Platinum-tin bimetallic catalyst for quinoline compound reduction methylation and preparation method and application thereof | 浙江大学衢州研究院 | 2023-12-05 | — | — | CN | claimed |
| EP-4635565-A1 | PRENYLATED TETRAHYDROQUINOLINES AND QUINOLINES WITH PPAR AGONIST ACTIVITY | Fundación para la Investigación del Hospital Clínico de la Comunidad Valenciana (INCLIVA) (ES) | 2025-10-22 | — | — | EP | disclosed |
| US-12344600-B2 | c-Myc mRNA translation modulators and uses thereof in the treatment of cancer | ANIMA BIOTECH INC. (US) | 2025-07-01 | — | — | US | disclosed |
| CN-120136645-A | Synthesis method and application of aromatic amine and indole compound containing hexafluoroisopropanol structural unit | 海南大学 | 2025-06-13 | — | — | CN | disclosed |
| US-20250109128-A1 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | ANIMA BIOTECH INC. (US) | 2025-04-03 | — | — | US | disclosed |
| CN-118382612-A | Method for producing blocked isocyanate compound and method for producing isocyanate compound | 旭化成株式会社 | 2024-07-23 | — | — | CN | disclosed |
| CN-118290350-A | Heteroaryl and bisheteroaryl derivatives for the treatment of iron death-related disorders | 协同医药发展有限公司 | 2024-07-05 | — | — | CN | disclosed |
| US-20240199638-A1 | GLUTARIMIDES FOR MEDICAL TREATMENT | C4 THERAPEUTICS, INC. (US) | 2024-06-20 | — | — | US | disclosed |
| CN-118125962-A | Method for preparing 2-aminomethylindoline-3-carboxylic acid from carbon dioxide | 常州大学 | 2024-06-04 | — | — | CN | disclosed |
| CN-116239529-B | Preparation method of N-methyltetrahydroquinoline alkaloid with participation of carbon dioxide | 山西大学 | 2024-05-24 | — | — | CN | disclosed |
| WO-2023132841-A1 | IMPROVING OUTCOMES AND RESPONSE TIMES FOR PATIENTS IN CRITICAL CARE SETTINGS | POSTREL RICHARD (US) | 2023-07-13 | — | — | WO | disclosed |
| WO-2023106377-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | 旭化成株式会社 | 2023-06-15 | — | — | WO | disclosed |
| CN-116239529-A | Preparation method of N-methyltetrahydroquinoline alkaloid with participation of carbon dioxide | 山西大学 | 2023-06-09 | — | — | CN | disclosed |
| CN-116239529-A | Preparation method of N-methyltetrahydroquinoline alkaloid with participation of carbon dioxide | 山西大学 | 2023-06-09 | — | — | CN | disclosed |
| CN-115160098-B | Oxygen-containing compound deoxidization methylation method | 中国科学院兰州化学物理研究所 | 2023-06-06 | — | — | CN | disclosed |
| US-20230088214-A1 | GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE | BIOMARIN PHARMACEUTICAL INC. (US) | 2023-03-23 | — | — | US | disclosed |
| US-20230089374-A1 | GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE | BIOMARIN PHARMACEUTICAL INC. (US) | 2023-03-23 | — | — | US | disclosed |
| US-20230079913-A1 | GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE | BIOMARIN PHARMACEUTICAL INC. (US) | 2023-03-16 | — | — | US | disclosed |
| US-11384055-B2 | Glycolate oxidase inhibitors for the treatment of disease | BIOMARIN PHARMACEUTICAL INC. (US) | 2022-07-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230079913-A1 | GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE | XDH, PNPO, AGXT | ALDH1A1 481/4885MEN1 2988/4885KMT2A 4011/4885 |
| US-20230088214-A1 | GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE | XDH, PNPO, AGXT | ALDH1A1 552/4885MEN1 2927/4885KMT2A 3699/4885 |
| US-11384055-B2 | Glycolate oxidase inhibitors for the treatment of disease | XDH, PNPO, AGXT | ALDH1A1 481/4885MEN1 2988/4885KMT2A 4011/4885 |
| US-20230089374-A1 | GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE | XDH, PNPO, AGXT | ALDH1A1 481/4885MEN1 2988/4885KMT2A 4011/4885 |
| US-20240199638-A1 | GLUTARIMIDES FOR MEDICAL TREATMENT | CRBN, GCDH, GCLC | ALDH1A1 1593/4885MEN1 2114/4885KMT2A 1703/4885 |
| US-12344600-B2 | c-Myc mRNA translation modulators and uses thereof in the treatment of cancer | MYC, MYCBP, MYCBP2 | ALDH1A1 4471/4885MEN1 1569/4885KMT2A 1404/4885 |
| US-20250109128-A1 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | MYC, MYCBP, MYCBP2 | ALDH1A1 4471/4885MEN1 1569/4885KMT2A 1404/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.